1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Pharmaceutical Drug Delivery Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Pharmaceutical Drug Delivery Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increasing Prevalence of Chronic Diseases and Infectious Diseases
- 5.1.2 Increasing Demand for Non-Invasive Drug Delivery
5.2 Market Opportunities
- 5.2.1 Focus on Improving Patient Compliance
5.4 Impact of Drivers and Restraints
6. Europe Pharmaceutical Drug Delivery Market Regional Analysis
6.1 Europe Pharmaceutical Drug Delivery Market Overview
6.2 Europe Pharmaceutical Drug Delivery Market Revenue 2017-2027 (US$ Million)
6.3 Europe Pharmaceutical Drug Delivery Market Forecast Analysis
7. Europe Pharmaceutical Drug Delivery Market Analysis – by Route of Administration
7.1 Oral Drug Delivery
- 7.1.1 Overview
- 7.1.2 Oral Drug Delivery: Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Injectable Drug Delivery
- 7.2.1 Overview
- 7.2.2 Injectable Drug Delivery: Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Topical Drug Delivery
- 7.3.1 Overview
- 7.3.2 Topical Drug Delivery: Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Ocular Drug Delivery
- 7.4.1 Overview
- 7.4.2 Ocular Drug Delivery: Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Pulmonary Drug Delivery
- 7.5.1 Overview
- 7.5.2 Pulmonary Drug Delivery: Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Nasal Drug Delivery
- 7.6.1 Overview
- 7.6.2 Nasal Drug Delivery: Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Transmucosal Drug Delivery
- 7.7.1 Overview
- 7.7.2 Transmucosal Drug Delivery: Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Implantable Drug Delivery
- 7.8.1 Overview
- 7.8.2 Implantable Drug Delivery: Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Pharmaceutical Drug Delivery Market Analysis – by Application
8.1 Infectious Diseases
- 8.1.1 Overview
- 8.1.2 Infectious Diseases: Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Cancer
- 8.2.1 Overview
- 8.2.2 Cancer: Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Cardiovascular Diseases
- 8.3.1 Overview
- 8.3.2 Cardiovascular Diseases: Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Diabetes
- 8.4.1 Overview
- 8.4.2 Diabetes: Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Respiratory Diseases
- 8.5.1 Overview
- 8.5.2 Respiratory Diseases: Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Central Nervous System Disorders
- 8.6.1 Overview
- 8.6.2 Central Nervous System Disorders: Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.7 Autoimmune Diseases
- 8.7.1 Overview
- 8.7.2 Autoimmune Diseases: Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.8 Other Diseases
- 8.8.1 Overview
- 8.8.2 Other Diseases: Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9. Europe Pharmaceutical Drug Delivery Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Other Diseases: Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Home Care Settings
- 9.2.1 Overview
- 9.2.2 Other Diseases: Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.3 ASC/Clinics
- 9.3.1 Overview
- 9.3.2 Other Diseases: Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Other End Users
- 9.4.1 Overview
- 9.4.2 Other Diseases: Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
10. Europe Pharmaceutical Drug Delivery Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe Pharmaceutical Drug Delivery Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.1.1.1 Europe Pharmaceutical Drug Delivery Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.1.1 UK: Europe Pharmaceutical Drug Delivery Market Breakdown, by Route of Administration
- 10.1.1.1.2 UK: Europe Pharmaceutical Drug Delivery Market Breakdown, by Application
- 10.1.1.1.3 UK: Europe Pharmaceutical Drug Delivery Market Breakdown, by End User
- 10.1.1.2 Germany:
Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.2.1 Germany: Europe Pharmaceutical Drug Delivery Market Breakdown, by Route of Administration
- 10.1.1.2.2 Germany: Europe Pharmaceutical Drug Delivery Market Breakdown, by Application
- 10.1.1.2.3 Germany: Europe Pharmaceutical Drug Delivery Market Breakdown, by End User
- 10.1.1.3 France:
Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.3.1 France: Europe Pharmaceutical Drug Delivery Market Breakdown, by Route of Administration
- 10.1.1.3.2 France: Europe Pharmaceutical Drug Delivery Market Breakdown, by Application
- 10.1.1.3.3 France: Europe Pharmaceutical Drug Delivery Market Breakdown, by End User
- 10.1.1.4 Russia:
Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.4.1 Russia: Europe Pharmaceutical Drug Delivery Market Breakdown, by Route of Administration
- 10.1.1.4.2 Russia: Europe Pharmaceutical Drug Delivery Market Breakdown, by Application
- 10.1.1.4.3 Russia: Europe Pharmaceutical Drug Delivery Market Breakdown, by End User
- 10.1.1.5 Italy:
Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.5.1 Italy: Europe Pharmaceutical Drug Delivery Market Breakdown, by Route of Administration
- 10.1.1.5.2 Italy: Europe Pharmaceutical Drug Delivery Market Breakdown, by Application
- 10.1.1.5.3 Italy: Europe Pharmaceutical Drug Delivery Market Breakdown, by End User
- 10.1.1.6 Rest of Europe:
Europe Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe Pharmaceutical Drug Delivery Market Breakdown, by Route of Administration
- 10.1.1.6.2 Rest of Europe: Europe Pharmaceutical Drug Delivery Market Breakdown, by Application
- 10.1.1.6.3 Rest of Europe: Europe Pharmaceutical Drug Delivery Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe Pharmaceutical Drug Delivery Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Bayer AG
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 GlaxoSmithKline plc,
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 MERCK KGaA
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Pfizer Inc.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Novartis AG
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
14. Appendix
14.1 About Business Market Insights